Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Regulus Therapeutics Inc. (RGLS) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Regulus Therapeutics Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1505512.
Total stock buying since 2015: $47,059,905.
Total stock sales since 2015: $13,786,538.
Total stock option exercises since 2015: $403,432.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 69,610 | $75,036 | 0 | $0 | 6,325 | $59,906 |
| 2024 | 4,000 | $7,280 | 25,516 | $30,388 | 0 | $0 |
| 2022 | 123,314 | $26,862 | 0 | $0 | 0 | $0 |
| 2021 | 0 | $0 | 9,158 | $12,276 | 0 | $0 |
| 2020 | 43,986,020 | $27,359,300 | 33,218 | $24,628 | 0 | $0 |
| 2019 | 14,166,531 | $15,299,848 | 101,818 | $112,193 | 0 | $0 |
| 2018 | 673,501 | $858,378 | 0 | $0 | 0 | $0 |
| 2017 | 2,324,175 | $2,267,896 | 0 | $0 | 0 | $0 |
| 2016 | 10,000 | $71,900 | 0 | $0 | 0 | $0 |
| 2015 | 110,000 | $1,093,405 | 896,381 | $13,607,053 | 510,677 | $343,526 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-06 | 0 | $0 | 0 | $0 | 6,325 | $59,906 |
| 2025-01 | 69,610 | $75,036 | 0 | $0 | 0 | $0 |
| 2024-07 | 4,000 | $7,280 | 0 | $0 | 0 | $0 |
| 2024-01 | 0 | $0 | 25,516 | $30,388 | 0 | $0 |
| 2022-02 | 23,314 | $5,362 | 0 | $0 | 0 | $0 |
| 2022-01 | 100,000 | $21,500 | 0 | $0 | 0 | $0 |
| 2021-05 | 0 | $0 | 4,186 | $3,725 | 0 | $0 |
| 2021-02 | 0 | $0 | 4,972 | $8,551 | 0 | $0 |
| 2020-12 | 43,986,020 | $27,359,300 | 0 | $0 | 0 | $0 |
| 2020-11 | 0 | $0 | 6,970 | $3,630 | 0 | $0 |
| 2020-08 | 0 | $0 | 5,117 | $3,095 | 0 | $0 |
| 2020-05 | 0 | $0 | 5,335 | $3,344 | 0 | $0 |
| 2020-02 | 0 | $0 | 5,212 | $4,325 | 0 | $0 |
| 2020-01 | 0 | $0 | 10,584 | $10,234 | 0 | $0 |
| 2019-11 | 0 | $0 | 6,671 | $4,269 | 0 | $0 |
| 2019-10 | 0 | $0 | 11,089 | $7,573 | 0 | $0 |
| 2019-08 | 0 | $0 | 5,274 | $2,905 | 0 | $0 |
| 2019-07 | 0 | $0 | 10,677 | $14,007 | 0 | $0 |
| 2019-05 | 14,166,531 | $15,299,848 | 56,302 | $71,859 | 0 | $0 |
| 2019-04 | 0 | $0 | 11,805 | $11,580 | 0 | $0 |
| 2018-12 | 166,401 | $167,867 | 0 | $0 | 0 | $0 |
| 2018-11 | 507,100 | $690,511 | 0 | $0 | 0 | $0 |
| 2017-07 | 1,824,175 | $1,659,996 | 0 | $0 | 0 | $0 |
| 2017-03 | 500,000 | $607,900 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-06-17 | Collier Kathryn J | Option Ex | 4,929 | 9.35 | 46,086 |
| 2025-06-16 | Collier Kathryn J | Option Ex | 1,396 | 9.90 | 13,820 |
| 2025-01-30 | Hagan Joseph P (Chief Executive Officer) | Buy | 50,000 | 1.08 | 54,250 |
| 2025-01-30 | Baltimore David | Buy | 19,610 | 1.06 | 20,786 |
| 2024-07-25 | Collier Kathryn J | Buy | 4,000 | 1.82 | 7,280 |
| 2024-01-18 | Aker Christopher Ray (Sr. VP & General Counsel) | Sale | 5,468 | 1.19 | 6,512 |
| 2024-01-18 | Calsada Crispina (Chief Financial Officer) | Sale | 5,468 | 1.19 | 6,512 |
| 2024-01-18 | Hagan Joseph P (Chief Executive Officer) | Sale | 14,580 | 1.19 | 17,364 |
| 2022-02-04 | Drygin Denis (Chief Scientific Officer) | Buy | 23,314 | .23 | 5,362 |
| 2022-01-26 | Hagan Joseph P (President and CEO) | Buy | 100,000 | .21 | 21,500 |
| 2021-05-17 | Hagan Joseph P (President and CEO) | Sale | 4,186 | .89 | 3,725 |
| 2021-02-16 | Aker Christopher Ray (Sr. VP & General Counsel) | Sale | 828 | 1.72 | 1,424 |
| 2021-02-16 | Hagan Joseph P (President and CEO) | Sale | 4,144 | 1.72 | 7,127 |
| 2020-12-04 | Chang Carmen (10% Owner) | Buy | 4,398,602 | .62 | 2,735,930 |
| 2020-12-04 | Nea 16 Gp, Llc (10% Owner) | Buy | 4,398,602 | .62 | 2,735,930 |
| 2020-12-04 | Makhzoumi Mohamad (10% Owner) | Buy | 4,398,602 | .62 | 2,735,930 |
| 2020-12-04 | Behbahani Ali (10% Owner) | Buy | 4,398,602 | .62 | 2,735,930 |
| 2020-12-04 | Florence Anthony A. Jr. (10% Owner) | Buy | 4,398,602 | .62 | 2,735,930 |
| 2020-12-04 | Sonsini Peter W. (10% Owner) | Buy | 4,398,602 | .62 | 2,735,930 |
| 2020-12-04 | Walker Paul Edward (10% Owner) | Buy | 4,398,602 | .62 | 2,735,930 |
| 2020-12-04 | Baskett Forest (10% Owner) | Buy | 4,398,602 | .62 | 2,735,930 |
| 2020-12-04 | Sandell Scott D (10% Owner) | Buy | 4,398,602 | .62 | 2,735,930 |
| 2020-12-04 | Makower Joshua (10% Owner) | Buy | 4,398,602 | .62 | 2,735,930 |
| 2020-11-16 | Aker Christopher Ray (Sr. VP & General Counsel) | Sale | 876 | .52 | 456 |
| 2020-11-16 | Hagan Joseph P (President and CEO) | Sale | 6,094 | .52 | 3,174 |
| 2020-08-14 | Aker Christopher Ray (Sr. VP & General Counsel) | Sale | 872 | .60 | 527 |
| 2020-08-14 | Hagan Joseph P (President and CEO) | Sale | 4,245 | .60 | 2,568 |
| 2020-05-15 | Aker Christopher Ray (Sr. VP & General Counsel) | Sale | 909 | .63 | 569 |
| 2020-05-15 | Hagan Joseph P (President and CEO) | Sale | 4,426 | .63 | 2,775 |
| 2020-02-18 | Aker Christopher Ray (Sr. VP & General Counsel) | Sale | 888 | .83 | 737 |
| 2020-02-18 | Hagan Joseph P (President and CEO) | Sale | 4,324 | .83 | 3,588 |
| 2020-01-02 | Aker Christopher Ray (Sr. VP & General Counsel) | Sale | 2,239 | .97 | 2,165 |
| 2020-01-02 | Hagan Joseph P (President and CEO) | Sale | 8,345 | .97 | 8,069 |
| 2019-11-14 | Aker Christopher Ray (Sr. VP & General Counsel) | Sale | 833 | .64 | 533 |
| 2019-11-14 | Hagan Joseph P (President and CEO) | Sale | 5,838 | .64 | 3,736 |
| 2019-10-01 | Aker Christopher Ray (Sr. VP & General Counsel) | Sale | 2,346 | .68 | 1,602 |
| 2019-10-01 | Hagan Joseph P (President and CEO) | Sale | 8,743 | .68 | 5,971 |
| 2019-08-15 | Aker Christopher Ray (Sr. VP & General Counsel) | Sale | 899 | .55 | 495 |
| 2019-08-15 | Hagan Joseph P (President and CEO) | Sale | 4,375 | .55 | 2,410 |
| 2019-07-01 | Aker Christopher Ray (Sr. VP & General Counsel) | Sale | 2,225 | 1.31 | 2,919 |
| 2019-07-01 | Chevallard Daniel R. (Chief Financial Officer) | Sale | 2,669 | 1.31 | 3,501 |
| 2019-07-01 | Hagan Joseph P (President and CEO) | Sale | 5,783 | 1.31 | 7,587 |
| 2019-05-16 | Hagan Joseph P (President and CEO) | Sale | 39,352 | 1.22 | 47,970 |
| 2019-05-15 | Aker Christopher Ray (Sr. VP & General Counsel) | Sale | 6,950 | 1.41 | 9,799 |
| 2019-05-15 | Chevallard Daniel R. (Chief Financial Officer) | Sale | 10,000 | 1.41 | 14,090 |
| 2019-05-07 | Chang Carmen (10% Owner) | Buy | 1,136,704 | 1.08 | 1,227,640 |
| 2019-05-07 | Nea 16 Gp, Llc (10% Owner) | Buy | 1,136,704 | 1.08 | 1,227,640 |
| 2019-05-07 | Witz Pascale (Director) | Buy | 29,630 | 1.08 | 32,000 |
| 2019-05-07 | Makhzoumi Mohamad (10% Owner) | Buy | 1,136,704 | 1.08 | 1,227,640 |
| 2019-05-07 | Behbahani Ali (10% Owner) | Buy | 1,136,704 | 1.08 | 1,227,640 |
| 2019-05-07 | Florence Anthony A. Jr. (10% Owner) | Buy | 1,136,704 | 1.08 | 1,227,640 |
| 2019-05-07 | Sonsini Peter W. (10% Owner) | Buy | 1,136,704 | 1.08 | 1,227,640 |
| 2019-05-07 | Walker Paul Edward (Director) | Buy | 1,136,704 | 1.08 | 1,227,640 |
| 2019-05-07 | Hagan Joseph P (President and CEO) | Buy | 33,194 | 1.08 | 35,849 |
| 2019-05-07 | Baskett Forest (10% Owner) | Buy | 1,136,704 | 1.08 | 1,227,640 |
| 2019-05-07 | Sandell Scott D (10% Owner) | Buy | 1,136,704 | 1.08 | 1,227,640 |
| 2019-05-07 | Makower Joshua (10% Owner) | Buy | 1,136,704 | 1.08 | 1,227,640 |
| 2019-05-07 | Mott David M (10% Owner) | Buy | 1,136,704 | 1.08 | 1,227,640 |
| 2019-05-07 | Rastetter William H (Director) | Buy | 92,889 | 1.08 | 100,320 |
| 2019-05-07 | Papadopoulos Stelios (Director) | Buy | 370,370 | 1.08 | 399,999 |
| 2019-05-07 | Barris Peter J (10% Owner) | Buy | 1,136,704 | 1.08 | 1,227,640 |
| 2019-04-01 | Aker Christopher Ray (Sr. VP & General Counsel) | Sale | 2,710 | .98 | 2,658 |
| 2019-04-01 | Chevallard Daniel R. (Chief Financial Officer) | Sale | 3,253 | .98 | 3,191 |
| 2019-04-01 | Hagan Joseph P (President and CEO) | Sale | 5,842 | .98 | 5,731 |
| 2018-12-28 | Papadopoulos Stelios (Director) | Buy | 50,000 | 1.09 | 54,550 |
| 2018-12-27 | Papadopoulos Stelios (Director) | Buy | 26,401 | 1.04 | 27,457 |
| 2018-12-26 | Papadopoulos Stelios (Director) | Buy | 90,000 | .95 | 85,860 |
| 2018-11-16 | Collier Kathryn J (Director) | Buy | 7,100 | 1.41 | 10,011 |
| 2018-11-16 | Papadopoulos Stelios (Director) | Buy | 300,000 | 1.39 | 415,500 |
| 2018-11-15 | Papadopoulos Stelios (Director) | Buy | 200,000 | 1.32 | 265,000 |
| 2017-07-25 | Chevallard Daniel R. (Chief Financial Officer) | Buy | 54,945 | .91 | 49,999 |
| 2017-07-25 | Wright Timothy Michael (Chief R & D Officer) | Buy | 274,725 | .91 | 249,999 |
| 2017-07-25 | Hagan Joseph P (President and CEO) | Buy | 219,780 | .91 | 199,999 |
| 2017-07-25 | Rastetter William H (Director) | Buy | 274,725 | .91 | 249,999 |
| 2017-07-25 | Papadopoulos Stelios (Director) | Buy | 1,000,000 | .91 | 910,000 |
| 2017-03-22 | Papadopoulos Stelios (Director) | Buy | 300,000 | 1.23 | 368,100 |
| 2017-03-21 | Papadopoulos Stelios (Director) | Buy | 200,000 | 1.20 | 239,800 |
| 2016-03-03 | Hagan Joseph P (Chief Operating Officer) | Buy | 10,000 | 7.19 | 71,900 |
| 2015-08-13 | Foletta Mark G (Director) | Buy | 10,000 | 7.64 | 76,410 |
| 2015-08-07 | Papadopoulos Stelios (Director) | Option Ex | 50,677 | 1.59 | 80,728 |
| 2015-07-21 | Rastetter William H (Director) | Buy | 61,235 | 10.19 | 624,229 |
| 2015-07-20 | Rastetter William H (Director) | Buy | 38,765 | 10.13 | 392,766 |
| 2015-07-17 | Isis Pharmaceuticals Inc (10% Owner) | Sale | 111,000 | 10.21 | 1,133,754 |
| 2015-07-16 | Isis Pharmaceuticals Inc (10% Owner) | Sale | 167,000 | 10.79 | 1,801,429 |
| 2015-07-15 | Isis Pharmaceuticals Inc (10% Owner) | Sale | 65,133 | 10.76 | 700,961 |
| 2015-06-30 | Isis Pharmaceuticals Inc (10% Owner) | Sale | 13,248 | 10.79 | 143,012 |
| 2015-04-21 | Xanthopoulos Kleanthis G (President and CEO) | Sale | 60,000 | 17.73 | 1,063,980 |
| 2015-04-21 | Xanthopoulos Kleanthis G (President and CEO) | Option Ex | 60,000 | .38 | 22,800 |
| 2015-04-20 | Xanthopoulos Kleanthis G (President and CEO) | Sale | 66,071 | 16.85 | 1,113,494 |
| 2015-04-20 | Xanthopoulos Kleanthis G (President and CEO) | Option Ex | 66,071 | .38 | 25,106 |
| 2015-04-17 | Xanthopoulos Kleanthis G (President and CEO) | Sale | 73,929 | 16.93 | 1,251,987 |
| 2015-04-17 | Xanthopoulos Kleanthis G (President and CEO) | Option Ex | 73,929 | .38 | 28,093 |
| 2015-04-13 | Carter Bruce L A (Director) | Sale | 20,000 | 17.66 | 353,160 |
| 2015-04-13 | Carter Bruce L A (Director) | Option Ex | 20,000 | 4.78 | 95,600 |
| 2015-03-05 | Xanthopoulos Kleanthis G (President and CEO) | Sale | 89,230 | 20.44 | 1,823,771 |
| 2015-03-05 | Xanthopoulos Kleanthis G (President and CEO) | Option Ex | 89,230 | .38 | 33,907 |
| 2015-02-27 | Xanthopoulos Kleanthis G (President and CEO) | Sale | 70 | 19.50 | 1,365 |
| 2015-02-27 | Xanthopoulos Kleanthis G (President and CEO) | Option Ex | 70 | .38 | 26 |
| 2015-02-02 | Xanthopoulos Kleanthis G (President and CEO) | Sale | 2,400 | 19.77 | 47,440 |
| 2015-02-02 | Xanthopoulos Kleanthis G (President and CEO) | Option Ex | 2,400 | .38 | 912 |
| 2015-01-30 | Xanthopoulos Kleanthis G (President and CEO) | Sale | 3,300 | 19.50 | 64,350 |
| 2015-01-30 | Xanthopoulos Kleanthis G (President and CEO) | Option Ex | 3,300 | .38 | 1,254 |
| 2015-01-29 | Xanthopoulos Kleanthis G (President and CEO) | Sale | 60,000 | 18.08 | 1,085,040 |
| 2015-01-29 | Xanthopoulos Kleanthis G (President and CEO) | Option Ex | 60,000 | .38 | 22,800 |
| 2015-01-28 | Gibson Neil W (Chief Scientific Officer) | Sale | 80,000 | 18.32 | 1,465,600 |
| 2015-01-28 | Xanthopoulos Kleanthis G (President and CEO) | Sale | 85,000 | 18.33 | 1,557,710 |
| 2015-01-28 | Xanthopoulos Kleanthis G (President and CEO) | Option Ex | 85,000 | .38 | 32,300 |
Insider trading activities including stock purchases, stock sales, and option exercises of RGLS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Regulus Therapeutics Inc. (symbol RGLS, CIK number 1505512) see the Securities and Exchange Commission (SEC) website.